DIALYSIS · CCN 212640

DaVita Renal Care of Seat Pleasant

SEAT PLEASANT, MD 20743

DialysisProfitDaVita
$6.0M
TOTAL REVENUE
19.3%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.0M
Total costs
$4.8M
Operating income (rev − costs)
$1.1M
Operating margin
19.3%
Total charges
$6.0M
Total treatments
14,196
Dialysis stations
21

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.294—
Fistula Rate
DFC_FISTULA_RATE
44.789—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.9233—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
109.688—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.15——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1789—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
19362—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
14.894—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
22.163—
Standardized ED Visits Ratio
DFC_SEDR
0.8963—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
6.255—